HUT72491A - Novel mono- and bicyclic dna gyrase inhibitors - Google Patents

Novel mono- and bicyclic dna gyrase inhibitors Download PDF

Info

Publication number
HUT72491A
HUT72491A HU9500860A HU9500860A HUT72491A HU T72491 A HUT72491 A HU T72491A HU 9500860 A HU9500860 A HU 9500860A HU 9500860 A HU9500860 A HU 9500860A HU T72491 A HUT72491 A HU T72491A
Authority
HU
Hungary
Prior art keywords
formula
group
groups
methyl
hydroxy
Prior art date
Application number
HU9500860A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9500860D0 (en
Inventor
Juergen Geiwiz
Erwin Goetschi
Paul Hebeisen
Helmut Link
Thomas Luebbers
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HU9500860D0 publication Critical patent/HU9500860D0/hu
Publication of HUT72491A publication Critical patent/HUT72491A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9500860A 1994-03-30 1995-03-24 Novel mono- and bicyclic dna gyrase inhibitors HUT72491A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94104995 1994-03-30
EP95101595 1995-02-07

Publications (2)

Publication Number Publication Date
HU9500860D0 HU9500860D0 (en) 1995-05-29
HUT72491A true HUT72491A (en) 1996-05-28

Family

ID=26135552

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9500860A HUT72491A (en) 1994-03-30 1995-03-24 Novel mono- and bicyclic dna gyrase inhibitors

Country Status (15)

Country Link
US (3) US5589473A (de)
EP (1) EP0675122A3 (de)
JP (1) JP2695132B2 (de)
KR (1) KR950032185A (de)
CN (2) CN1114648A (de)
AU (1) AU694936B2 (de)
CA (1) CA2144499A1 (de)
CZ (1) CZ78895A3 (de)
FI (1) FI951514A7 (de)
HU (1) HUT72491A (de)
IL (1) IL113123A (de)
NO (1) NO304024B1 (de)
NZ (1) NZ270801A (de)
RU (1) RU95104899A (de)
TW (1) TW343965B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
US5922883A (en) * 1996-04-03 1999-07-13 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP4101846B1 (de) 2003-04-11 2023-08-02 PTC Therapeutics, Inc. 1,2,4-oxadiazolbenzoesäureverbindungen und deren verwendung zur nonsense-unterdrückung und behandlung von krankheiten
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds
FR2866887A1 (fr) * 2004-02-27 2005-09-02 Oreal Para-phenylenediamine secondaire n-heteroaryle, compositon tinctoriale comprenant une telle para-phenylenediamine, procede mettant en oeuvre cette composition et utilisation
US7329288B2 (en) 2004-02-27 2008-02-12 L'oreal S.A. N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof
GB0500683D0 (en) 2005-01-13 2005-02-23 Novartis Ag Organic compounds
US7820674B2 (en) * 2005-01-19 2010-10-26 Merck, Sharp & Dohme Corp. Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
AU2006230364B2 (en) * 2005-03-31 2012-09-13 Janssen Pharmaceutica N.V. Bicyclic pyrazole compounds as antibacterial agents
EP2387995A1 (de) 2006-03-30 2011-11-23 PTC Therapeutics, Inc. Verfahren zur Produktion von funktionellem Protein aus DNA mit Nonsense-Mutation und Behandlung von damit assoziierten Erkrankungen
US7829709B1 (en) 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
US8173809B2 (en) * 2008-02-07 2012-05-08 Marquette University Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
CA2721433A1 (en) * 2008-04-16 2009-11-12 Marquette University Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
EP2603080A4 (de) * 2010-08-12 2014-01-22 Enanta Pharm Inc Hemmer des hepatitis-c-virus
WO2012173410A2 (en) * 2011-06-14 2012-12-20 Green Cross Corporation Novel c-aryl ansa sglt2 inhibitors
SI2994465T1 (sl) 2013-05-10 2018-10-30 Karus Therapeutics Limited Novi inhibitorji histon deacetilaze
WO2015134711A1 (en) 2014-03-06 2015-09-11 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
GB201419228D0 (en) * 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
TW201729807A (zh) 2015-10-30 2017-09-01 Ｐｔｃ治療公司 用於治療癲癇的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05508167A (ja) * 1991-04-17 1993-11-18 エフ・ホフマン―ラ　ロシュ　アーゲー 新規なｄｎａジャイレース阻害剤、その製造方法およびそれらを含有する製薬学的製剤

Also Published As

Publication number Publication date
AU694936B2 (en) 1998-08-06
FI951514A0 (fi) 1995-03-30
HU9500860D0 (en) 1995-05-29
NZ270801A (en) 1997-01-29
FI951514A7 (fi) 1995-10-01
CN1114648A (zh) 1996-01-10
JP2695132B2 (ja) 1997-12-24
US5589473A (en) 1996-12-31
JPH07285953A (ja) 1995-10-31
IL113123A (en) 1999-11-30
NO951210D0 (no) 1995-03-29
CZ78895A3 (en) 1995-12-13
IL113123A0 (en) 1995-06-29
US5594135A (en) 1997-01-14
AU1507095A (en) 1995-10-12
CN1308071A (zh) 2001-08-15
NO951210L (no) 1995-10-02
NO304024B1 (no) 1998-10-12
EP0675122A3 (de) 1997-11-05
TW343965B (en) 1998-11-01
US5665746A (en) 1997-09-09
EP0675122A2 (de) 1995-10-04
CA2144499A1 (en) 1995-10-01
RU95104899A (ru) 1997-01-10
KR950032185A (ko) 1995-12-20

Similar Documents

Publication Publication Date Title
US5594135A (en) Tricyclic DNA gyrase inhibitors
EP2305657B1 (de) Oxazolidinone Derivative
US5457111A (en) Macrocyclic immunomodulators
AU2009278929B2 (en) Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity
JP2006519247A (ja) 抗生物質として有用なヒドロキシメチル置換ジヒドロイソオキサゾール誘導体
US5744465A (en) Method of inhibiting a β-lactamase enzyme by administering novel 2-thiosubstituted carbapenems
MXPA97000886A (en) New oxazolidinones sustitui
CZ187395A3 (en) Five-membered heteroaryl-oxazolidinones, their use and medicaments in which said compounds are comprised
NO327010B1 (no) Oksazolidinon og/eller isoksazolin anvendelse derav som antibakterielle midler, farmasoytisk sammensetning og fremgangsmate for fremstilling derav
WO2008143649A2 (en) Novel oxazolidinone compounds as antiinfective agents
JP2005519870A (ja) 抗菌活性をもつアリール置換オキサゾリジノン類
JP2006512352A (ja) オキサゾリジノン誘導体及び抗菌薬としてのそれらの使用
AU2003209994A1 (en) Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
JPH10508285A (ja) カルバペネム化合物、組成物および治療方法
US5294609A (en) DNA gyrase inhibitors and pharmaceutical preparations therefor
US4897489A (en) Antibiotic derivatives, their production and use
JPS63152384A (ja) ３環性セファムまたはイソセファム化合物，その製造法および用途
EP0399645B1 (de) Tetrahydropyranylderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische oder tiermedizinische Zusammensetzungen
US4876251A (en) Tricyclic penam compounds, their production and their use
JP4208243B2 (ja) 抗微生物性ジヒドロチアジンおよびジヒドロチオピランオキサゾリジノン
CA1292985C (en) Tricyclic penam compounds, their production and their use
WO1987000527A1 (fr) Composes antibacteriens, leur utilisation et procede de preparation
JPS62215583A (ja) ピラゾリジノン誘導体およびその製造法

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal